Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
Clinical trial NCT05972551 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05972551
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-22
- Primary completion
- 2027-05-04
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.